Distamycin analogues with enhanced lipophilicity: synthesis and antimicrobial activity. 2004

Abedawn I Khalaf, and Roger D Waigh, and Allan J Drummond, and Breffni Pringle, and Ian McGroarty, and Graham G Skellern, and Colin J Suckling
Department of Pure & Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow G1 1XL, Scotland, U.K.

Forty-eight heterocyclic amino acid trimers, analogues of distamycin, with a number of features that enhance lipophilicity are described. They contain alkyl or cycloalkyl groups larger than methyl; some are N-terminated by acetamide or methoxybenzamide and are C-terminated by dimethylaminopropyl or aliphatic heterocylic aminopropyl substituents. The ability of these compounds to bind principally to AT tracts of DNA has been evaluated using capillary zone electrophoresis. Significant antimicrobial activity against key organisms such as MRSA and Candida albicans is shown by several compounds, especially those containing a thiazole. Moreover, these compounds have low toxicity with respect to several mammalian cell lines.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004214 Distamycins Oligopeptide antibiotics from Streptomyces distallicus. Their binding to DNA inhibits synthesis of nucleic acids.
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics

Related Publications

Abedawn I Khalaf, and Roger D Waigh, and Allan J Drummond, and Breffni Pringle, and Ian McGroarty, and Graham G Skellern, and Colin J Suckling
February 2022, Chemistry & biodiversity,
Abedawn I Khalaf, and Roger D Waigh, and Allan J Drummond, and Breffni Pringle, and Ian McGroarty, and Graham G Skellern, and Colin J Suckling
June 1994, Acta chemica Scandinavica (Copenhagen, Denmark : 1989),
Abedawn I Khalaf, and Roger D Waigh, and Allan J Drummond, and Breffni Pringle, and Ian McGroarty, and Graham G Skellern, and Colin J Suckling
April 2011, Molecules (Basel, Switzerland),
Abedawn I Khalaf, and Roger D Waigh, and Allan J Drummond, and Breffni Pringle, and Ian McGroarty, and Graham G Skellern, and Colin J Suckling
November 1986, Anti-cancer drug design,
Abedawn I Khalaf, and Roger D Waigh, and Allan J Drummond, and Breffni Pringle, and Ian McGroarty, and Graham G Skellern, and Colin J Suckling
January 2015, Clujul medical (1957),
Abedawn I Khalaf, and Roger D Waigh, and Allan J Drummond, and Breffni Pringle, and Ian McGroarty, and Graham G Skellern, and Colin J Suckling
January 1997, Pharmacology & therapeutics,
Abedawn I Khalaf, and Roger D Waigh, and Allan J Drummond, and Breffni Pringle, and Ian McGroarty, and Graham G Skellern, and Colin J Suckling
September 2002, Bioorganic & medicinal chemistry letters,
Abedawn I Khalaf, and Roger D Waigh, and Allan J Drummond, and Breffni Pringle, and Ian McGroarty, and Graham G Skellern, and Colin J Suckling
January 2021, Bioorganic chemistry,
Abedawn I Khalaf, and Roger D Waigh, and Allan J Drummond, and Breffni Pringle, and Ian McGroarty, and Graham G Skellern, and Colin J Suckling
July 2019, The Journal of organic chemistry,
Abedawn I Khalaf, and Roger D Waigh, and Allan J Drummond, and Breffni Pringle, and Ian McGroarty, and Graham G Skellern, and Colin J Suckling
July 2003, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!